Tech Company Financing Transactions

GnuBio Funding Round

GnuBio, based in Cambridge, raised $10 million from private investors.

Transaction Overview

Company Name
Announced On
10/2/2012
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1 Kendall Square Bldg 1400 14201
Cambridge, MA 02139
USA
Email Address
Overview
GnuBIO is a genomics company developing next-generation sequencing technology for the molecular diagnostic and applied research markets. The GnuBIO system is based on emulsion and microfluidic technology developed at Harvard University.
Profile
GnuBio LinkedIn Company Profile
Social Media
GnuBio Company Twitter Account
Company News
GnuBio News
Facebook
GnuBio on Facebook
YouTube
GnuBio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Boyce
  John Boyce LinkedIn Profile  John Boyce Twitter Account  John Boyce News  John Boyce on Facebook
Chief Financial Officer
Susie Harborth
  Susie Harborth LinkedIn Profile  Susie Harborth Twitter Account  Susie Harborth News  Susie Harborth on Facebook
VP - Product Management
Sepehr Kiani
  Sepehr Kiani LinkedIn Profile  Sepehr Kiani Twitter Account  Sepehr Kiani News  Sepehr Kiani on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/2/2012: Diffusion Pharmaceuticals venture capital transaction
Next: 10/2/2012: Bottlenose venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary